Latest Insider Transactions at Syneos Health, Inc. (SYNH)
This section provides a real-time view of insider transactions for Syneos Health, Inc. (SYNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Syneos Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Syneos Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 02
2022
|
Michelle Keefe Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+6.55%
|
-
|
Mar 02
2022
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,761
-10.5%
|
$2,140,880
$80.75 P/Share
|
Mar 02
2022
|
Alistair Macdonald Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,816
+6.66%
|
-
|
Mar 02
2022
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,453
-9.39%
|
$516,240
$80.75 P/Share
|
Mar 02
2022
|
Jason M. Meggs Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,200
+6.57%
|
-
|
Mar 02
2022
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Payment of exercise price or tax liability
|
Direct |
4,100
-12.97%
|
$328,000
$80.75 P/Share
|
Mar 02
2022
|
Jonathan Olefson General Counsel & Corp Secty |
BUY
Grant, award, or other acquisition
|
Direct |
8,430
+8.31%
|
-
|
Feb 16
2022
|
Michael Lee Brooks Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,847
-9.79%
|
$319,301
$83.37 P/Share
|
Jan 31
2022
|
Donna Hildebrand Kralowetz EVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,055
-13.63%
|
$94,950
$90.0 P/Share
|
Jan 18
2022
|
Barbara W. Bodem Director |
BUY
Grant, award, or other acquisition
|
Direct |
654
+48.92%
|
-
|
Jan 18
2022
|
Alfonso G Zulueta Director |
BUY
Grant, award, or other acquisition
|
Direct |
654
+50.0%
|
-
|
Jan 18
2022
|
Michael Lee Brooks Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
3,400
+23.87%
|
-
|
Jan 18
2022
|
Michael Lee Brooks Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,296
-14.83%
|
$111,456
$86.09 P/Share
|
Jan 18
2022
|
Michael Lee Brooks Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,415
+15.87%
|
-
|
Jan 18
2022
|
Michael Lee Brooks Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,114
-3.38%
|
$95,804
$86.09 P/Share
|
Jan 18
2022
|
Michelle Keefe Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,712
+14.3%
|
-
|
Jan 18
2022
|
Michelle Keefe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,382
-8.07%
|
$290,852
$86.09 P/Share
|
Jan 18
2022
|
Donna Hildebrand Kralowetz EVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,831
+19.13%
|
-
|
Jan 18
2022
|
Donna Hildebrand Kralowetz EVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
558
-8.63%
|
$47,988
$86.09 P/Share
|
Jan 18
2022
|
Alistair Macdonald Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,498
+13.17%
|
-
|
Jan 18
2022
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,028
-8.1%
|
$1,292,408
$86.09 P/Share
|
Jan 18
2022
|
Jason M. Meggs Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,890
+14.03%
|
-
|
Jan 18
2022
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,179
-6.52%
|
$273,394
$86.09 P/Share
|
Jan 18
2022
|
Jonathan Olefson General Counsel & Corp Secty |
BUY
Grant, award, or other acquisition
|
Direct |
6,121
+21.08%
|
-
|
Jan 18
2022
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Payment of exercise price or tax liability
|
Direct |
2,370
-12.37%
|
$203,820
$86.09 P/Share
|
Jan 10
2022
|
Jason M. Meggs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,700
-3.37%
|
$158,100
$93.69 P/Share
|
Jan 10
2022
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Payment of exercise price or tax liability
|
Direct |
1,616
-7.78%
|
$150,288
$93.69 P/Share
|
Jan 10
2022
|
Michelle Keefe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,085
-4.74%
|
$193,905
$93.69 P/Share
|
Jan 10
2022
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,154
-5.19%
|
$944,322
$93.69 P/Share
|
Dec 30
2021
|
Michael Lee Brooks Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
93
-1.05%
|
$9,579
$103.0 P/Share
|
Dec 23
2021
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Open market or private sale
|
Direct |
1,889
-8.33%
|
$188,900
$100.95 P/Share
|
Dec 22
2021
|
Michael Lee Brooks Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
93
-1.04%
|
$9,207
$99.0 P/Share
|
Dec 20
2021
|
Linda S Harty Director |
SELL
Open market or private sale
|
Direct |
4,122
-44.38%
|
$399,834
$97.02 P/Share
|
Dec 16
2021
|
Michael Lee Brooks Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
603
-6.33%
|
$59,094
$98.9 P/Share
|
Dec 01
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
1,000
-1.94%
|
-
|
Nov 15
2021
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Payment of exercise price or tax liability
|
Direct |
1,632
-6.72%
|
$159,936
$98.37 P/Share
|
Nov 05
2021
|
Jonathan Olefson General Counsel & Corp Secty |
SELL
Bona fide gift
|
Direct |
237
-0.97%
|
-
|
Sep 03
2021
|
Donna Hildebrand Kralowetz EVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
248
-3.69%
|
$23,312
$94.3 P/Share
|
Sep 03
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,223
-15.19%
|
$876,185
$95.0 P/Share
|
Aug 03
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
35,553
-7.9%
|
$3,128,664
$88.16 P/Share
|
Aug 03
2021
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,553
+13.32%
|
$1,493,226
$42.76 P/Share
|
Aug 02
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,710
-2.35%
|
$419,190
$89.9 P/Share
|
Jul 16
2021
|
Matthew E. Monaghan Director |
SELL
Open market or private sale
|
Direct |
170
-0.98%
|
$14,960
$88.64 P/Share
|
Jul 06
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
660
-0.54%
|
$59,400
$90.0 P/Share
|
Jul 06
2021
|
Jason M. Meggs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
660
+0.53%
|
$29,040
$44.58 P/Share
|
Jun 30
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,668
-3.7%
|
$420,120
$90.0 P/Share
|
Jun 30
2021
|
Jason M. Meggs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,668
+3.57%
|
$200,724
$43.02 P/Share
|
Jun 18
2021
|
Donna Hildebrand Kralowetz EVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
590
-8.36%
|
$50,150
$85.03 P/Share
|
Jun 17
2021
|
Donna Hildebrand Kralowetz EVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
250
-3.42%
|
$21,250
$85.44 P/Share
|
Jun 15
2021
|
David S. Wilkes Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,134
+50.0%
|
-
|